L
LLY
Lilly Eli & Co
738.64
11.43+1.57%After Hours: 735.66 -2.98 -0.40%17:03 09/08 EDT
OPEN/PREV CLOSE729.71/727.21
TODAY RANGE719.22-742.70
VOL4.53M
MARKET CAP699.09B
52 WEEK RANGE622.41-935.20
AVG VOL (3M)4.42M
% TURNOVER0.48%
TURNOVER--
P/E (TTM)48.25
% RANGE3.23%
EPS(TTM)15.31
P/E(FORWARD)33.35
P/B38.27
BVPS19.30
DIVIDEND6.00
P/S15.54
BETA--
DIV YIELD0.81%
FREE FLOAT MKT CAP697.53B
SHARES OUTSTANDING946.46M
NEXT EARNINGS02/04-02/10
FREE FLOAT944.35M
LOT SIZE1
EX-DATE08/15/2025
News
Press Releases
Financial Reports
Profile
TipRanks·51m ago
Eli Lilly’s (LLY) Leukemia Drug Shows Promise in Clinical Trial
Seeking Alpha·1h ago
Eli Lilly hires former FDA cell and gene therapies official Rachael Anatol
Simply Wall St·3h ago
Eli Lilly (LLY) Announces Promising Results For Jaypirca In CLL Phase 3 Trial
Benzinga·4h ago
Eli Lilly's Jaypirca Surpasses Chemoimmunotherapy For Untreated Blood Cancer Patients
Seeking Alpha·5h ago
Wall Street Lunch: Tesla Market Share Struggles
NASDAQ·6h ago
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Benzinga·6h ago
Ozempic Is The New Botox And Big Pharma Is Printing Billions
Seeking Alpha·7h ago
Eli Lilly succeeds in late-stage leukemia treatment trial
Simply Wall St·8h ago
Eli Lilly (LLY): Assessing Valuation Following Breakthrough Lung Cancer and Obesity Drug Milestones
Seeking Alpha·9h ago
Eli Lilly: Why Wall Street Still Loves Its GLP-1 Agonist Drugs
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.